HY23 swung to a $5m pre-tax loss as revenue and EBITDA roughly halved

What changed

Revenue fell 56.9% to $208.0m from $483.0m and EBITDA fell to $164.0m from $347.0m. Operating profit dropped to $46.0m from $132.0m, and the result swung to a $5.0m pre-tax loss and a $4.0m net loss, against an HY22 PBT of $61.0m and NPAT of $42.0m. Operating cash flow was $148.0m versus $290.0m, capex was $193.0m versus $263.0m, and pre-lease free cash flow turned negative at -$45.0m against +$27.0m a year earlier. Gross borrowings were $1,975.0m and cash was $26.0m, giving net debt of about $1,949.0m versus $2,274.0m in HY22, with total equity up to $1,555.0m. The interim dividend was cut to 12.5cps from 14.0cps.

What matters

• Earnings quality has deteriorated sharply. PBT fell 108.2% and NPAT fell 109.5%; the small divergence is driven by a $1.0m tax benefit against the pre-tax loss versus a normal 31.1% effective rate in HY22. PBT is the cleaner operating read and it has turned negative.
• Leverage on an earnings basis has weakened despite lower gross debt. Net debt improved by about $325m, but because EBITDA fell further, net debt to EBITDA has stepped up to 11.9x from 6.6x.
• Capital allocation is now running against free cash flow. The cut interim dividend (12.5cps) is being paid out of a period where pre-lease FCF was -$45.0m and the payout ratio versus NPAT is not meaningful because NPAT is negative.

Expectations

No forward target or formal guidance was supplied in the current-period materials, so the release cannot be judged against a stated number. On shape, the HY22 anchor carried 50.1% of full-year revenue and 51.4% of full-year EBITDA, so the comparable period was not obviously second-half-weighted. Annualised HY23 revenue of about $416m sits well below the FY22 reference of $965m, which indicates the run-rate implied by this half is materially below the prior full-year base rather than being recoverable purely through normal seasonality.

Quality of result

Cash conversion within the half was actually strong in isolation — OCF to EBITDA was 90.2% versus 83.6% a year earlier, and receivable days tightened to about 41 from 47 — so the operating cash decline is primarily earnings-driven rather than working-capital-driven. The problem is below that line: capex at $193.0m was 92.8% of revenue versus 54.5% in HY22, so even with disciplined working capital the half did not self-fund. The tax line flatters NPAT slightly via a benefit on the loss, but the core story is the revenue and EBITDA step-down, which looks structural on the figures supplied rather than timing-driven.

Unresolved

• The supplied materials do not include a current-period release narrative, so the drivers of the revenue and EBITDA step-down — whether regulatory reset effects, accounting treatment changes, contract mix, or a segment-specific decline — are not identified. No segment split or concentration disclosure was provided.
• There is no reconciliation of EBITDA as a non-GAAP measure in the supplied excerpts and no explicit non-recurring items, so it is unclear how much of the earnings fall is adjusted-through versus underlying.
• There is no stated FY23 EBITDA, capex, or dividend target in the current-period extract, so sustainability of the 12.5cps interim relative to free cash flow over the full year cannot be tested.

This briefing cannot assess valuation, regulatory-price-path context, or any management commentary not included in the supplied excerpts.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.